About Ridgeback Capital Management
Ridgeback Capital Management is a private equity firm founded in 2006. It is primarily based in New York City, United States.
Overall Ridgeback Capital Management portfolio has seen 1 unicorn, 40 IPOs and 39 acquisitions including key companies like Alnylam, Amgen and Peloton. A lot of funds co-invest with Ridgeback Capital Management, with names like Janus Henderson Investors sharing a substantial percentage of its portfolio.
Ridgeback Capital Management has a team of 4 people, including 3 partners.
Key Metrics
Ridgeback Capital Management's Portfolio
They have invested in a total of 94 companies. Their most recent investment was in Hinge Bio (Series A round) on Jan 15, 2025. Here is the most recent investment by Ridgeback Capital Management:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jan 15, 2025 | Series A | 3043 | ||
Feb 27, 2024 | Post IPO | 9236 | ||
Dec 03, 2021 | Series B | 2043 | and 16 others | |
Nov 29, 2021 | Series B | 7842 | and 9 others |
Here is the portfolio snapshot of Ridgeback Capital Management:
Investments by Year
The maximum number of investments were made in 2021
Team profile of Ridgeback Capital Management
Ridgeback Capital Management has a team of 4 members including 3 Partners located in United States. Ridgeback Capital Management's team does not sit on the board of any company as of now.Here is a list of all team members in Ridgeback Capital Management:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York City | - | ||
Partner | Miami | - | ||
Partner | New York | - |
Co-investors of Ridgeback Capital Management
Over the past 20 years, 153 investors have co-invested in Ridgeback Capital Management's portfolio companies.
- Top Co-investors of Ridgeback Capital Management: 153 investors entered a company along with Ridgeback Capital Management. These include investors like Janus Henderson Investors (6 companies).
Ridgeback Capital Management News
•
Avidian Wealth Solutions Acquires Ridgeback Capital Management, Expanding Houston PresencePRWeb•Jul 21, 2026•Avidian Wealth Solutions, Ridgeback Capital Management
•
Hinge Bio Raises $30 Million Series A' Financing To Develop Next-generation Therapies Via Its Proprietary Gem-dimer PlatformBenzinga•Jan 15, 2025•Hinge Bio, Ridgeback Capital Management, InVivium Capital, Lightswitch Capital and 1 other
•
Hinge Bio Raises $30M in Series A FinancingFinSMEs•Jan 15, 2025•Hinge Bio, Point72, Ridgeback Capital Management, InVivium Capital and 1 other
•
LENZ Therapeutics gets $30M investment from Ridgeback CapitalSeeking Alpha•Jul 15, 2024•LENZ Therapeutics, Ridgeback Capital Management, Wilson Sonsini Goodrich & Rosati
•
Housebuilder GS8 wins £650m investment from TPG Angelo Gordon and RidgebackProperty Week•Jun 07, 2024•GS8, Angelo Gordon, Ridgeback Capital Management, TPG
•
Nkarta announces pricing of stock offering to raise $240.1MSeeking Alpha•Mar 25, 2024•Nkarta Therapeutics, Adage Capital Management, Boxer Capital, Commodore Capital and 14 others
•
Freenome Lands $300 Million Series D for Early Cancer Detectionsvdaily.com•Dec 10, 2021•Freenome Health, Perceptive Advisors, RA Capital Management, Andreessen Horowitz and 26 others
•
FYLD raises £10 million in Series A fundingAngel News•Nov 30, 2021•Fyld, Ridgeback Capital Management, SV Health Investors, Fidelity Investments and 8 others
•
Quell raises US$156m for Treg cell therapy programmeEuropean Biotechnology•Nov 30, 2021•Quell, British Patient Capital, Jeito, Ridgeback Capital Management and 8 others
•
Arbor Biotechnologies raises $215m through Series B roundPharmaceutical Business Review•Nov 10, 2021•Arbor Biotechnologies, Ally Bridge Group, TCG Crossover, Temasek and 13 others
